• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: IBSA FARMACEUTICI ITALIA SRL GELSYN-3 ZILRETTA; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

IBSA FARMACEUTICI ITALIA SRL GELSYN-3 ZILRETTA; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems High Blood Pressure/ Hypertension (1908); Itching Sensation (1943); Swelling (2091); Chills (2191); Dizziness (2194)
Event Date 12/05/2018
Event Type  Injury  
Event Description
Injection of gelsyn-3 into both knees done 3 times: date (b)(6) 2018, (b)(6) 2018, (b)(6) 2018.Result: blood pressure high, dizziness, chills off and on, lack of appetite, itching, swelling.Injection at medical center.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GELSYN-3 ZILRETTA
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
IBSA FARMACEUTICI ITALIA SRL
MDR Report Key8339466
MDR Text Key136745083
Report NumberMW5084046
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 02/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/13/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator No Information
Was Device Available for Evaluation? No
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Disability;
Patient Age88 YR
Patient Weight72
-
-